latest update:
[RxAtlas]

drug summary · 2 NDC codes

INVOKAMET XR 150 mg/1; 500 mg/1

canagliflozin and metformin hydrochloride

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 142044NDC codes 2application NDA205879RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namecanagliflozin and metformin hydrochloride
active ingredientsCANAGLIFLOZIN, METFORMIN HYDROCHLORIDE
dosage formTABLET, FILM COATED, EXTENDED RELEASE
routeORAL
strength150 mg/1; 500 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA205879
ATC codenot reported
RxCUInot reported
manufacturerJanssen Pharmaceuticals, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classBiguanide [EPC]; Biguanides [CS]; P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
50458-942—
50458094201—

Other canagliflozin and metformin hydrochloride products

7 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.